======= KDM1A ======= == Gene Information == * **Official Symbol**: KDM1A * **Official Name**: lysine demethylase 1A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23028|23028]] * **UniProt**: [[https://www.uniprot.org/uniprot/O60341|O60341]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KDM1A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KDM1A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609132|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a nuclear protein containing a SWIRM domain, a FAD-binding motif, and an amine oxidase domain. This protein is a component of several histone deacetylase complexes, though it silences genes by functioning as a histone demethylase. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]. * **UniProt Summary**: N/A |SWIRM| |DAO| |Amino oxidase| |telomeric repeat-containing RNA binding| |histone demethylase activity (H3-dimethyl-K4 specific)| |guanine metabolic process| |positive regulation of histone ubiquitination| |histone demethylase activity (H3-K4 specific)| |MRF binding| |negative regulation of histone H3-K4 methylation| |DNA repair complex| |demethylase activity| |histone H3-K4 demethylation| |regulation of histone ubiquitination| |positive regulation of cell size| |negative regulation of histone H3-K9 methylation| |response to fungicide| |positive regulation of chromatin binding| |histone demethylase activity (H3-K9 specific)| |histone H3-K9 demethylation| |negative regulation of DNA damage response, signal transduction by p53 class mediator| |histone demethylase activity| |negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator| |alternative mRNA splicing, via spliceosome| |regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator| |negative regulation of histone methylation| |purine nucleobase metabolic process| |positive regulation of neuroblast proliferation| |negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator| |regulation of histone H3-K9 methylation| |regulation of chromatin binding| |telomeric DNA binding| |regulation of histone H3-K4 methylation| |histone lysine demethylation| |histone demethylation| |cellular response to gamma radiation| |regulation of intrinsic apoptotic signaling pathway by p53 class mediator| |negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage| |protein demethylation| |protein dealkylation| |regulation of neuroblast proliferation| |negative regulation of signal transduction by p53 class mediator| |regulation of DNA damage response, signal transduction by p53 class mediator| |neuron maturation| |positive regulation of stem cell proliferation| |regulation of intrinsic apoptotic signaling pathway in response to DNA damage| |negative regulation of histone modification| |nucleobase metabolic process| |androgen receptor binding| |regulation of double-strand break repair via homologous recombination| |positive regulation of neural precursor cell proliferation| |cellular response to cAMP| |negative regulation of DNA binding| |response to gamma radiation| |flavin adenine dinucleotide binding| |negative regulation of chromatin organization| |RNA polymerase II transcription factor binding| |demethylation| |regulation of stem cell proliferation| |nuclear receptor transcription coactivator activity| |regulation of histone methylation| |p53 binding| |cellular response to ionizing radiation| |regulation of double-strand break repair| |negative regulation of response to DNA damage stimulus| |cellular response to UV| |regulation of neural precursor cell proliferation| |positive regulation of histone modification| |negative regulation of intrinsic apoptotic signaling pathway| |positive regulation of cold-induced thermogenesis| |response to cAMP| |negative regulation of protein binding| |regulation of DNA recombination| |positive regulation of chromatin organization| |nuclear chromosome, telomeric region| |cellular response to light stimulus| |positive regulation of protein ubiquitination| |cerebral cortex development| |oxidoreductase activity| |regulation of DNA repair| |regulation of DNA binding| |positive regulation of protein modification by small protein conjugation or removal| |negative regulation of chromosome organization| |anatomical structure maturation| |response to organophosphorus| |response to UV| |regulation of cold-induced thermogenesis| |regulation of histone modification| |response to ionizing radiation| |muscle cell development| |response to purine-containing compound| |cell maturation| |negative regulation of DNA-binding transcription factor activity| |regulation of intrinsic apoptotic signaling pathway| |negative regulation of binding| |pallium development| |positive regulation of chromosome organization| |cellular response to radiation| |positive regulation of binding| |regulation of signal transduction by p53 class mediator| |regulation of cell size| |regulation of chromatin organization| |regulation of protein ubiquitination| |transcription factor complex| |regulation of response to DNA damage stimulus| |transcription regulatory region DNA binding| |regulation of protein binding| |negative regulation of apoptotic signaling pathway| |regulation of protein modification by small protein conjugation or removal| |nuclear chromatin| |developmental maturation| |muscle cell differentiation| |telencephalon development| |positive regulation of DNA-binding transcription factor activity| |positive regulation of neuron projection development| |blood coagulation| |coagulation| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |hemostasis| |RNA splicing, via transesterification reactions| |response to antibiotic| |response to light stimulus| |cellular response to abiotic stimulus| |cellular response to environmental stimulus| |transcription factor binding| |enzyme binding| |regulation of chromosome organization| |regulation of DNA metabolic process| |histone modification| |purine-containing compound metabolic process| |positive regulation of neuron differentiation| |negative regulation of organelle organization| |covalent chromatin modification| |regulation of cellular component size| |regulation of binding| |positive regulation of cell projection organization| |forebrain development| |chromatin binding| |RNA splicing| |regulation of apoptotic signaling pathway| |regulation of DNA-binding transcription factor activity| |response to radiation| |positive regulation of neurogenesis| |muscle structure development| |mRNA processing| |wound healing| |regulation of body fluid levels| |regulation of neuron projection development| |response to toxic substance| |negative regulation of intracellular signal transduction| |regulation of anatomical structure size| |positive regulation of nervous system development| |regulation of cellular protein localization| |nucleobase-containing small molecule metabolic process| |positive regulation of cell development| |cellular response to organic cyclic compound| |response to wounding| |negative regulation of protein modification process| |protein-containing complex| |cellular response to organonitrogen compound| |positive regulation of organelle organization| |regulation of neuron differentiation| |cellular response to nitrogen compound| |regulation of plasma membrane bounded cell projection organization| |mRNA metabolic process| |chromatin organization| |negative regulation of cellular component organization| |regulation of cell projection organization| |regulation of cellular response to stress| |brain development| |head development| |neuron development| |regulation of neurogenesis| |negative regulation of transcription by RNA polymerase II| |RNA processing| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |positive regulation of cell population proliferation| |regulation of cellular localization| |response to organic cyclic compound| |regulation of nervous system development| |regulation of cell development| |oxidation-reduction process| |positive regulation of cell differentiation| |central nervous system development| |negative regulation of cell death| |response to organonitrogen compound| |neuron differentiation| |regulation of protein localization| |negative regulation of cellular protein metabolic process| |cellular response to oxygen-containing compound| |chromosome organization| |response to nitrogen compound| |negative regulation of protein metabolic process| |negative regulation of molecular function| |response to abiotic stimulus| |negative regulation of transcription, DNA-templated| |positive regulation of cellular component organization| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |regulation of organelle organization| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |generation of neurons| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |regulation of programmed cell death| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |RNA metabolic process| |regulation of cell death| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |small molecule metabolic process| |positive regulation of molecular function| |regulation of cell differentiation| |regulation of intracellular signal transduction| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.71| |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|1.72| |[[:results:exp141|Nifurtimox 1μM R03 exp141]]|1.75| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|1.81| |[[:results:exp293|Myriocin 25μM R06 exp293]]|1.87| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|1.89| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.94| |[[:results:exp485|GSK626616 14μM R08 exp485]]|1.95| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|1.96| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|1.98| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|2.04| |[[:results:exp11|CCCP 1μM R00 exp11]]|2.12| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|2.12| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.18| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|2.18| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.19| |[[:results:exp151|SGC0946 7μM R03 exp151]]|2.22| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|2.25| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.37| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.43| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|2.62| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|2.68| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|3.33| ^Gene^Correlation^ |[[:human genes:r:rcor1|RCOR1]]|0.436| Global Fraction of Cell Lines Where Essential: 2/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2548 * **Expression level (log2 read counts)**: 7.64 {{:chemogenomics:nalm6 dist.png?nolink |}}